Purpose: MRI proton density fat fraction (PDFF) can be calculated using magnitude (MRI-M) or complex (MRI-C) MRI data. The purpose of this study was to identify, assess, and compare the accuracy of common PDFF thresholds for MRI-M and MRI-C for assessing hepatic steatosis in patients with obesity, using histology as reference.

Methods: This two-center prospective study included patients undergoing MRI-C- and MRI-M-PDFF estimations within 3 days before weight loss surgery. Liver biopsy was performed, and histology-determined steatosis grades were used as reference standard. Using receiver operating characteristics (ROC) analysis on data pooled from both methods, single common thresholds for diagnosing and differentiating none or mild (0-1) from moderate to severe steatosis (2-3) were selected as the ones achieving the highest sensitivity while providing at least 90% specificity. Selection methods were cross-validated. Performances were compared using McNemar's tests.

Results: Of 81 included patients, 54 (67%) had steatosis. The common PDFF threshold for diagnosing steatosis was 5.4%, which provided a cross-validated 0.88 (95% CI 0.77-0.95) sensitivity and 0.92 (0.75-0.99) specificity for MRI-M and 0.87 sensitivity (0.75-0.94) with 0.81 (0.61-0.93) specificity for MRI-C. The common PDFF threshold to differentiate steatosis grades 0-1 from 2 to 3 was 14.7%, which provided cross-validated 0.86 (95% CI 0.59-0.98) sensitivity and 0.95 (0.87-0.99) specificity for MRI-M and 0.93 sensitivity (0.68-0.99) with 0.97(0.89-0.99) specificity for MRI-C.

Conclusion: If independently validated, diagnostic thresholds of 5.4% and 14.7% could be adopted for both techniques for detecting and differentiating none to mild from moderate to severe steatosis, respectively, with high diagnostic accuracy.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108484PMC
http://dx.doi.org/10.1007/s00261-019-02350-3DOI Listing

Publication Analysis

Top Keywords

common pdff
12
accuracy common
8
proton density
8
density fat
8
fat fraction
8
assessing hepatic
8
steatosis
8
hepatic steatosis
8
steatosis patients
8
patients obesity
8

Similar Publications

Background & Aims: A common genetic variant (rs738409) encoding isoleucine to methionine at position 148 in the PNPLA3 protein is a determinant of hepatic steatosis, inflammation, fibrosis, cirrhosis, and liver-related mortality. AZD2693 is a liver-targeted antisense oligonucleotide against PNPLA3 mRNA. We evaluated the safety, tolerability, pharmacokinetics, and pharmacodynamics in single ascending dose (SAD) and multiple ascending dose (MAD) studies.

View Article and Find Full Text PDF
Article Synopsis
  • This study examines how marathon running impacts lumbar spine health, focusing on injuries and disc degeneration.
  • It compares 54 amateur marathon runners to 30 healthy participants using advanced imaging techniques to assess fat fraction, cross-sectional area of muscles, and T2 relaxation times of intervertebral discs.
  • Results indicate that marathon runners had notable differences in fat fraction and muscle cross-sectional area, suggesting changes in lumbar spine and surrounding tissues related to their running activities.
View Article and Find Full Text PDF

Metabolic dysfunction-associated steatotic liver disease and risk of four intrahepatic and extrahepatic diseases.

Ann Hepatol

December 2024

School of Public Health (Shenzhen), Sun Yat-sen University, No.66, Gongchang Road, Guangming District, Shenzhen, Guangdong, China; Shenzhen Key Laboratory of Pathogenic Microbes and Biosafety, School of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-sen University, No.66, Gongchang Road, Guangming District, Shenzhen, Guangdong, China. Electronic address:

Article Synopsis
  • - The study aims to explore the link between steatotic liver diseases (MASLD, MetALD, and ALD) and other health issues like liver, kidney, cardiovascular diseases, and cancers using data from the UK Biobank.
  • - Researchers diagnosed patients with MASLD, MetALD, and ALD based on specific imaging criteria, finding 6,865 MASLD, 2,379 MetALD, and 884 ALD cases among 39,230 participants.
  • - Results showed that all three liver diseases significantly increased the risk of liver problems, with MASLD also linked to higher renal risk, and ALD associated with an increased risk of cancer.
View Article and Find Full Text PDF

Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis describe a collection of liver conditions characterized by the accumulation of liver fat. Despite biopsy being the reference standard for determining the severity of disease, non-invasive measures such as magnetic resonance imaging proton density fat fraction (MRI-PDFF) and FibroScan® controlled attenuation parameter (CAP™) can be used to understand longitudinal changes in steatosis. The aim of this work was to describe the exposure-response relationship of ervogastat with or without clesacostat on steatosis, through population pharmacokinetic/pharmacodynamic (PK/PD) modeling of both liver fat measurements simultaneously.

View Article and Find Full Text PDF
Article Synopsis
  • Myosteatosis refers to the abnormal buildup of fat in skeletal muscle, which is associated with various health risks, including aging, chronic diseases, and lower muscle quality, but is distinct from sarcopenia.
  • It negatively impacts muscle function by causing inflammation and compromising mitochondrial efficiency, which can lead to decreased strength and mobility.
  • Current imaging techniques like CT, MRI, and ultrasound are used to assess myosteatosis, but there is no standardized definition or consensus on assessment methods in clinical practice.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!